Catalyst Wire Dossier Catalyst Wire Dossier

Fuzhenghuayu

Fuzhenghuayu
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Fuzhenghuayu, covering 2016-09-27 to 2016-09-27. Get the full timeline:

Most recent: Clinical Trial Update: Fuzhenghuayu in Combination With Ursodeoxycholic Acid in Primary Biliary Cirrhosis [Phase 3]

See pricing